COG-AALL06N1

Clinical Trial Title Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
Trial Status Closed to Enrollment
Start Date 04/16/2007
Location randall-childrens-hospital-at-legacy-emanuel
Trial Type Pediatric Cancer (Oncology)
Specific Condition Neurocognitive Function (ALL)
Description A Study of Neurocognitive Function in Children Treated for Acute Lymphoblastic Leukemia (ALL)
Eligibility Criteria Patient must have been >1 year and <18 years of age at the time diagnosed as having ALL

Patient must be enrolled on AALL0434 (Cohort #1 only) or AALL0232 (Cohort #1 and #2) and must have received either high dose methotrexate or escalating dose methotrexate during interim maintenance

Eligibility time period is 8-24 months post completion of AALL0232 protocol treatment
IRB Number
Notes

https://clinicaltrials.gov/ct2/show/NCT00437060

Study status is:
Completed: The study has ended normally, and participants are no longer being examined or treated (that is, the last participant's last visit has occurred).
Principal Investigator Janice Olson, MD
Contact Name Children's Cancer and Blood Disorders Program
Contact Phone (503) 276-9300
Contact Fax
Contact E-Mail